BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15713991)

  • 1. Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency.
    Symeonidis A; Kouraklis-Symeonidis A; Apostolopoulos D; Arvanitopoulou E; Giannakoulas N; Vassilakos P; Zoumbos N
    Oncology; 2004; 67(5-6):359-67. PubMed ID: 15713991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study.
    Ercan Ş; Kaymaz Ö; Yücel N; Orçun A
    Arch Gynecol Obstet; 2012 Mar; 285(3):579-84. PubMed ID: 21792548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megaloblastic marrow in macrocytic anaemias at Kenyatta National and M P Shah Hospitals, Nairobi.
    Mwanda OW; Dave P
    East Afr Med J; 1999 Nov; 76(11):610-4. PubMed ID: 10734519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of tumor markers in chronic hemodialysis patients.
    Tzitzikos G; Saridi M; Filippopoulou T; Makri A; Goulioti A; Stavropoulos T; Stamatiou K
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):50-3. PubMed ID: 20061692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA 15-3 predicting breast cancer relapse: beware of vitamin B12 deficiency.
    El Rassy E; Al Ghor M; Kattan J
    Per Med; 2018 May; 15(3):163-165. PubMed ID: 29745746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters.
    Christoforidis A; Lefkou E; Vlachaki E; Perifanis V; Tsatra I; Dogramatzi F; Athanassiou-Metaxa M
    Ann Hematol; 2007 Nov; 86(11):837-41. PubMed ID: 17668208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
    Yuksel BC; Yildiz Y; Ozturk B; Berkem H; Katman U; Ozel H; Hengirmen S
    Am J Surg; 2008 Apr; 195(4):452-6. PubMed ID: 18083135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional vitamin B12 deficiency in alcoholics: an intriguing finding in a retrospective study of megaloblastic anemic patients.
    Fragasso A; Mannarella C; Ciancio A; Sacco A
    Eur J Intern Med; 2010 Apr; 21(2):97-100. PubMed ID: 20206879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer.
    Lumachi F; Basso SM; Bonamini M; Marzano B; Milan E; Waclaw BU; Chiara GB
    Anticancer Res; 2010 Jun; 30(6):2331-4. PubMed ID: 20651388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cardiopulmonary resuscitation on levels of tumour markers.
    Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
    Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
    Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
    Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychiatric manifestations of vitamin B12 deficiency: a case report].
    Durand C; Mary S; Brazo P; Dollfus S
    Encephale; 2003; 29(6):560-5. PubMed ID: 15029091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of laboratory findings in megaloblastic anemia--measurement of serum vitamin B12 and methylmalonic acid].
    Kondo H; Kakinuma H; Kanazawa S; Iseki T; Goto S; Ohto M; Yonemitsu H; Okuda K
    Rinsho Ketsueki; 1989 Jan; 30(1):36-44. PubMed ID: 2654448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary partial transcobalamin II deficiency with neurologic, mental and hematologic abnormalities in children and adults.
    Teplitsky V; Huminer D; Zoldan J; Pitlik S; Shohat M; Mittelman M
    Isr Med Assoc J; 2003 Dec; 5(12):868-72. PubMed ID: 14689755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin B12 deficiency--a major cause of megaloblastic anaemia in patients attending a tertiary care hospital.
    Iqbal SP; Kakepoto GN; Iqbal SP
    J Ayub Med Coll Abbottabad; 2009; 21(3):92-4. PubMed ID: 20929023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Megaloblastic anemia: 30 cases in a district hospital].
    Olgiati ML; Mombelli G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):113-9. PubMed ID: 7878399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tumor markers in patients on dialysis and kidney transplantation.
    Lye WC; Tambyah P; Leong SO; Lee EJ
    Adv Perit Dial; 1994; 10():109-11. PubMed ID: 7528056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
    Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
    Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.